What’s Next for Cesca Therapeutics Inc. (KOOL) After Making 52 Week Low?

April 25, 2018 - By Richard Conner

Cesca Therapeutics Inc. (NASDAQ:KOOL) Logo

The stock of Cesca Therapeutics Inc. (NASDAQ:KOOL) hit a new 52-week low and has $1.33 target or 6.00 % below today’s $1.42 share price. The 8 months bearish chart indicates high risk for the $16.25M company. The 1-year low was reported on Apr, 25 by Barchart.com. If the $1.33 price target is reached, the company will be worth $974,820 less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock.

The stock decreased 8.12% or $0.125 during the last trading session, reaching $1.415. About 168,317 shares traded or 107.23% up from the average. Cesca Therapeutics Inc. (NASDAQ:KOOL) has declined 36.51% since April 25, 2017 and is downtrending. It has underperformed by 48.06% the S&P500.

Cesca Therapeutics Inc. develops, commercializes, and markets a range of automated technologies and products for cell therapeutics in the United States, China, rest of Asia, Europe, and internationally. The company has market cap of $16.25 million. The firm develops automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. It currently has negative earnings. It offers AutoXpress System, a proprietary automated device and companion sterile disposable for concentrating hematopoietic stem cells from cord blood; Point-of-CareXpress System, a proprietary automated device and companion sterile disposable for the isolation and concentration of hematopoietic stem cells from bone marrow; CAR-TXpress System, a suite of multi-component automated system that allows the automated manufacturing, expansion, and storage of cellular therapies for immuno-oncology; BioArchive System, an automated cryogenic device for single-cassette based cryo-storage of biological license applications products; and manual bag sets for use in the processing and cryogenic storage of cord blood.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.